Screener
Amylyx Pharmaceuticals, Inc. AMLX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s shares (diluted)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported shares (diluted) of 111.2M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s shares (diluted) increased by 24.7% year-over-year, from 89.1M to 111.2M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s shares (diluted) has grown at a 93.2% compound annual growth rate (CAGR), from 26M to 362.7M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude